News & Events
Nursing and Bioscience Tech Students Learn about Radiation Oncology in Interprofessional Experience
In February, FACT BSN nursing students and BS and MS Bioscience Technology students spent a day learning about radiation therapy and medical dosimetry from the experts.
Can Vitamin A Turn Back the Clock on Breast Cancer?
Pre-cancerous cells treated with a vitamin A derivative revert into non-cancerous cells.
Can Antibiotics Cause Autoimmunity?
Antibiotics being explored for the treatment of cystic fibrosis and muscular dystrophy have the potential to trigger autoimmune disease.
Radiation Therapy and Cancer Vaccines: Timing Is Everything
Treating tumors with radiotherapy first directly kills cancer cells and makes immunotherapy more effective.
A Message from Dr. Klasko
To keep patients healthy, we’re going to need a different, friendlier, and more collaborative kind of doctor. We’re going to need to develop measurable population health strategies. And we’re going to need to make lifelong learning fun. Those innovations will help us all.
Paul Summergrad, MD, President-Elect of American Psychiatric Association to Speak at Jefferson
Paul Summergrad, MD, Chair of the Psychiatry Department of Tufts University, Psychiatrist-in-Chief at Tufts Medical Center, and President-Elect of the American...
Two Tools Are Tested to Better Understand the Effects of Concussion on Patients' Brains
Study shows potential use for cerebral blood flow and dopamine transporter imaging to evaluate T.B.I. patients.
Breast Cancer Treatment Selection Is Improved by Genomic Tests at Jefferson Breast Care Center
Molecular subtyping enables more accurate prognosis and treatment selection, according to research presented at San Antonio Conference.
Melissa A. Lazar, MD Appointed Breast Surgeon at Jefferson Breast Care Center
Thomas Jefferson University Hospital has appointed Melissa A. Lazar, MD as a surgeon at the Jefferson Breast Care Center. She has also been appointed an Assistant Professor of...
Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer
A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson...